Evidence map›Paper›PMID 25393615›Full record

ArticleEuropean journal of immunology2015

T-cell STAT3 is required for the maintenance of humoral immunity to LCMV.

David R McIlwain, Melanie Grusdat, Vitaly I Pozdeev, Haifeng C Xu, Prashant Shinde, Colin Reardon, Zhenyue Hao, Marc Beyer, Andreas Bergthaler, Dieter Häussinger and 3 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 4 countries.

David R McIlwainDepartment of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany; Baxter Laboratory in Stem Cell Biology, Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA.
Melanie Grusdat
Vitaly I Pozdeev
Haifeng C Xu
Prashant Shinde
Colin Reardon
Zhenyue Hao
Marc Beyer
Andreas Bergthaler
Dieter Häussinger
Garry P Nolan
Karl S Lang
Philipp A Lang
Heinrich Heine University Düsseldorf · DEAustrian Academy of Sciences · ATBaxter (United States) · USOntario Institute for Cancer Research · CAUniversity of Bonn · DEUniversity of California, Davis · USUniversity of Duisburg-Essen · DEZero to Three · US

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
Systems Biology CoreU19AI100627 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ULEVITCH, RICHARD J · 2012 to 2021
$49.1M
MODELING THE ROLE OF PROGRESSION IN FOLLICULAR LYMPHOMAU54CA149145 · NCI · STANFORD UNIVERSITY · PI PLEVRITIS, SYLVIA KATINA · 2010 to 2014
$12.1M
(PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian CancersR01CA184968 · NCI · STANFORD UNIVERSITY · PI FANTL, WENDY JANE, SIKIC, BRANIMIR I · 2014 to 2017
$2.0M
Highly multiplexed ion-beam tissue molecular imaging with sub-micron resolutionR33CA183654 · NCI · STANFORD UNIVERSITY · PI NOLAN, GARRY P · 2014 to 2016
$1.2M
Integrating mass cytometric and transcriptomic profiles of solid tumorsR33CA183692 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WEISS, WILLIAM A · 2014 to 2016
$1.2M
Canadian Institutes of Health Research 201210MFE-289576-150035NCI NIH HHS 1 R33 CA183654NCI NIH HHS R01 CA184968NCI NIH HHS R01CA184968NCI NIH HHS R33 CA183654NCI NIH HHS R33 CA183692NCI NIH HHS U54 CA149145NCI NIH HHS U54CA149145NHLBI NIH HHS N01-HV-00242NIAID NIH HHS 1U19AI100627NIAID NIH HHS 5R01AI07372405NIAID NIH HHS U19 AI057229NIAID NIH HHS U19 AI100627PHS HHS 41000411217PHS HHS 7500108142PHS HHS HHSF223201210194C
6 · The paper itself

Abstract

STAT3 is a critical transcription factor activated downstream of cytokine signaling and is integral for the function of multiple immune cell types. Human mutations in STAT3 cause primary immunodeficiency resulting in impaired control of a variety of infections, including reactivation of latent viruses. In this study, we investigate how T-cell functions of STAT3 contribute to responses to viral infection by inducing chronic lymphocytic choriomeningitis virus (LCMV) infection in mice lacking STAT3 specifically in T cells. Although mice with conditional disruption of STAT3 in T cells were able to mount early responses to viral infection similar to control animals, including expansion of effector T cells, we found generation of T-follicular helper (Tfh) cells to be impaired. As a result, STAT3 T cell deficient mice produced attenuated germinal center reactions, and did not accumulate bone marrow virus specific IgG-secreting cells, resulting in failure to maintain levels of virus-specific IgG or mount neutralizing responses to LCMV in the serum. These effects were associated with reduced control of viral replication and prolonged infection. Our results demonstrate the importance of STAT3 in T cells for the generation of functional long-term humoral immunity to viral infections.

Indexed as

Immunity, HumoralAnimalsAntibodies, ViralB-LymphocytesChronic DiseaseGene ExpressionImmunoglobulin GImmunophenotypingLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMiceMice, KnockoutSignal TransductionSTAT3 Transcription FactorT-Lymphocytes, CytotoxicT-Lymphocytes, Helper-InducerAntibodies, ViralImmunoglobulin GStat3 protein, mouseSTAT3 Transcription FactorChronic infectionHumoral immunityLCMVSTAT3T follicular helper cells

Identifiers

PMID25393615
PMCPMC4383653
OpenAlexW1599424958

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.